Evidence-based Healthcare最新文献

No association between mobile phone usage and development of acoustic neuroma 手机使用与听神经瘤的发展无关联

Evidence-based Healthcare Pub Date : 2004-08-01 DOI: 10.1016/J.EHBC.2004.05.007

L. Hardell

引用次数: 2

Hormone replacement therapy is not safe for breast cancer survivors 激素替代疗法对乳腺癌幸存者来说并不安全

Evidence-based Healthcare Pub Date : 2004-08-01 DOI: 10.1016/J.EHBC.2004.05.004

R. Vassilopoulou-sellin

引用次数: 0

Laparoscopic hysterectomy is not cost effective compared with vaginal hysterectomy 与阴道子宫切除术相比，腹腔镜子宫切除术不具有成本效益

Evidence-based Healthcare Pub Date : 2004-08-01 DOI: 10.1016/J.EHBC.2004.05.014

B. Crawford

引用次数: 2

H. pylori eradication does not reduce gastric cancer incidence in a high-risk area of China 幽门螺杆菌根除并不能降低中国高风险地区胃癌的发病率

Evidence-based Healthcare Pub Date : 2004-08-01 Epub Date: 2004-07-02 DOI: 10.1016/j.ehbc.2004.05.005

Bor-Shyang Sheu MD (Commentary Author), Xi-Zhang Lin MD (Commentary Author)

{"title":"H. pylori eradication does not reduce gastric cancer incidence in a high-risk area of China","authors":"Bor-Shyang Sheu MD (Commentary Author), Xi-Zhang Lin MD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.005","DOIUrl":"https://doi.org/10.1016/j.ehbc.2004.05.005","url":null,"abstract":"<div><h3>Question</h3><p>Does treating <em>H. Pylori</em> reduce the incidence of gastric cancer?</p></div><div><h3>Study</h3><p>Randomised placebo-controlled trial.</p></div><div><h3>Main results</h3><p>At 7.5 years, incidence of gastric cancer was not significantly different between groups (treatment: 0.86%, <em>n=</em>7; placebo: 1.35%, <em>n</em>=11; <em>p</em>=0.33). In people without precancerous lesions at baseline, risk of gastric cancer was significantly lower for treatment compared with placebo (incidence of gastric cancer: treatment <em>n</em>=0; placebo <em>n</em>=6; <em>p</em>=0.02) but there was no difference among people with precancerous lesions (<em>n</em>=7 and 5, respectively). Smoking (hazard ratio [HR] 6.2, 95% CI 2.3 to 16.5) and older age (HR per 1 year 1.10, 95% CI 1.05 to 1.15) were independent predictors of gastric cancer risk.</p></div><div><h3>Authors’ conclusions</h3><p>Incidence of gastric cancer was similar between <em>H. pylori</em> eradication and placebo groups over 7.5 years of follow-up. However, it was significantly reduced in a subgroup of people without precancerous lesions at baseline.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 218-220"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction Retaplase + abciximab可改善糖尿病合并急性st段抬高型心肌梗死患者的非致命性预后，但不能改善总生存率

Evidence-based Healthcare Pub Date : 2004-08-01 Epub Date: 2004-07-15 DOI: 10.1016/j.ehbc.2004.05.001

Victor Serebruany MD, PhD (Commentary Author)

{"title":"Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction","authors":"Victor Serebruany MD, PhD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.001","DOIUrl":"https://doi.org/10.1016/j.ehbc.2004.05.001","url":null,"abstract":"<div><h3>Question</h3><p>In people with diabetes and ST-segment elevation myocardial infarction, is half-dose reteplase plus abciximab more effective than reteplase alone?</p></div><div><h3>Study design</h3><p>Secondary analysis of multicentre randomised controlled trial.</p></div><div><h3>Main results</h3><p>For mortality at 30 days or 1 year, there was no significant difference between groups (see Table 1). Reteplase plus abciximab significantly reduced the risk of reinfarction, or recurrent ischaemia or angina compared with reteplase alone.<span><div><div><table><tbody><tr><td><strong>Table 1</strong> Clinical outcomes for people with diabetes and ST-segment myocardial infarction.</td></tr><tr><td></td><td>Reteplase alone (<em>n</em>=1299)</td><td>Half-dose reteplase plus abciximab (<em>n</em>=1334)</td><td><em>P</em> value</td></tr><tr><td>Death within 30 days</td><td>8.8%</td><td>8.2%</td><td>0.57</td></tr><tr><td>Death within 1 year</td><td>13.0%</td><td>12.4%</td><td>0.64</td></tr><tr><td>Reinfarction</td><td>4.3%</td><td>2.5%</td><td>0.01</td></tr><tr><td>Recurrent ischaemia/angina</td><td>14.9%</td><td>11.8%</td><td>0.01</td></tr></tbody></table></div></div></span></p></div><div><h3>Authors’ conclusions</h3><p>Although treatment with reteplase plus abciximab did not provide a survival benefit for people with diabetes and ST-segment elevation myocardial infarction compared with reteplase alone, nonfatal outcomes including reinfarction and recurrent ischaemia were substantially reduced.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 230-231"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Link between diagnostic X-rays and cancer uncertain☆ 诊断x光与癌症之间的联系尚不明确

Evidence-based Healthcare Pub Date : 2004-08-01 DOI: 10.1016/J.EHBC.2004.05.011

J. Cameron

引用次数: 4

Unscheduled care for people with asthma in a multi-ethnic area is reduced following educational outreach programme by specialist nurses☆ 在一个多民族地区，通过专科护士的教育推广方案，减少了对哮喘患者的计划外护理

Evidence-based Healthcare Pub Date : 2004-08-01 DOI: 10.1016/J.EHBC.2004.05.017

A. Kamps

引用次数: 5

Intravenous magnesium sulphate does not improve survival or disability outcomes in people with stroke 静脉注射硫酸镁不能改善中风患者的生存或残疾结果

Evidence-based Healthcare Pub Date : 2004-08-01 DOI: 10.1016/J.EHBC.2004.05.002

S. Selco, B. Ovbiagele

引用次数: 1

Hormone replacement therapy is not safe for breast cancer survivors 激素替代疗法对乳腺癌幸存者来说并不安全

Evidence-based Healthcare Pub Date : 2004-08-01 Epub Date: 2004-07-15 DOI: 10.1016/j.ehbc.2004.05.004

Rena Vassilopoulou-Sellin MD (Commentary Author)

引用次数: 0

Attending a single care site associated with improved glycaemic control in people with diabetes 参加单一护理地点与改善糖尿病患者的血糖控制有关

Evidence-based Healthcare Pub Date : 2004-08-01 Epub Date: 2004-07-03 DOI: 10.1016/j.ehbc.2004.05.016

Peter Harvey (Commentary Author)

引用次数: 1